Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients With Aortic Regurgitation

NCT06608823 is registered in ClinicalTrials.gov with JenaValve Technology, Inc. as lead sponsor.

NCT NCT06608823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06608823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Assess Safety and Effectiveness of the JenaValve Trilogy™ Transcatheter Heart Valve System Versus Surgical Valve Replacement in Patients With Aortic Regurgitation
Lead sponsor
JenaValve Technology, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
June 18, 2025
Completion date
February 29, 2036
Enrollment
1,016 (estimated)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

aortic insufficiency, aortic regurgitation, aortic valve insufficiency